Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Pain Blocks in Urological Surgery
NCT04426500Phase 3Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Nov 2019
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of bupivacaine in postoperative pain (3 arms), sponsored by Icahn School of Medicine at Mount Sinai. Primary endpoint: Visual Analog Scale at 24 hours. Started Nov 2019; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04426500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04426500.